The protective role of neocuproine against cardiac damage in isolated perfused rat hearts. 1990

Y J Applebaum, and J Kuvin, and J B Borman, and G Uretzky, and M Chevion
Lunenfeld's Cardiac Surgery Research Center, Hadassah University Hospital, Jerusalem, Israel.

The effect of neocuproine on cardiac injury was studied using retrogradely perfused isolated rat hearts in two experimental systems. In the first system, where hydrogen peroxide-induced damage was studied, neocuproine at the range of 40-175 microM provided protection at the level of 70-85%, as demonstrated by the reduced loss in the peak systolic pressure (P), in +dP/dt and in -dP/dt. In the second system, where ischemia/reperfusion-induced arrhythmias were studied, neocuproine (42 microM) provided a marked protection against cardiac injury as demonstrated by the lowering of the incidence in irreversible ventricular fibrillation, by decreasing the duration of ventricular fibrillation and by the concomitant increase of the duration of normal sinus rhythm, and by improving the post-ischemic recovery of P, +dP/dt and -dP/dt. Free radicals have already been implicated as causative agents in cardiac injury resulting from either hydrogen peroxide or ischemia followed by reperfusion. Additionally, iron and copper have already been shown to drastically exacerbate the injurious effects of free radicals. Thus, the results reported here with neocuproine, a highly effective chelator for both iron and copper, as well as with adventitious copper and with the combination of neocuproine and copper, are in accord with the mediatory role of transition metals in enhancing the deleterious effects induced by free radicals.

UI MeSH Term Description Entries
D008297 Male Males
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D010618 Phenanthrolines Phenanthroline
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002317 Cardiovascular Agents Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. Cardioactive Agent,Cardioactive Drug,Cardiovascular Agent,Cardiovascular Drug,Cardioactive Agents,Cardioactive Drugs,Cardiovascular Drugs,Agent, Cardioactive,Agent, Cardiovascular,Drug, Cardioactive,Drug, Cardiovascular
D003300 Copper A heavy metal trace element with the atomic symbol Cu, atomic number 29, and atomic weight 63.55. Copper-63,Copper 63
D003326 Coronary Circulation The circulation of blood through the CORONARY VESSELS of the HEART. Circulation, Coronary
D003331 Coronary Vessels The veins and arteries of the HEART. Coronary Arteries,Sinus Node Artery,Coronary Veins,Arteries, Coronary,Arteries, Sinus Node,Artery, Coronary,Artery, Sinus Node,Coronary Artery,Coronary Vein,Coronary Vessel,Sinus Node Arteries,Vein, Coronary,Veins, Coronary,Vessel, Coronary,Vessels, Coronary

Related Publications

Y J Applebaum, and J Kuvin, and J B Borman, and G Uretzky, and M Chevion
February 2003, Shock (Augusta, Ga.),
Y J Applebaum, and J Kuvin, and J B Borman, and G Uretzky, and M Chevion
January 1991, Proceedings of the Western Pharmacology Society,
Y J Applebaum, and J Kuvin, and J B Borman, and G Uretzky, and M Chevion
April 1987, Cardiologia (Rome, Italy),
Y J Applebaum, and J Kuvin, and J B Borman, and G Uretzky, and M Chevion
January 1991, Archives of toxicology,
Y J Applebaum, and J Kuvin, and J B Borman, and G Uretzky, and M Chevion
October 1996, Critical care medicine,
Y J Applebaum, and J Kuvin, and J B Borman, and G Uretzky, and M Chevion
May 1993, The American journal of physiology,
Y J Applebaum, and J Kuvin, and J B Borman, and G Uretzky, and M Chevion
April 2018, Fundamental & clinical pharmacology,
Y J Applebaum, and J Kuvin, and J B Borman, and G Uretzky, and M Chevion
November 1994, Journal of molecular and cellular cardiology,
Y J Applebaum, and J Kuvin, and J B Borman, and G Uretzky, and M Chevion
December 2018, Mutation research. Genetic toxicology and environmental mutagenesis,
Y J Applebaum, and J Kuvin, and J B Borman, and G Uretzky, and M Chevion
July 2005, Annals of cardiac anaesthesia,
Copied contents to your clipboard!